Cargando…
Comparative single-cell RNA-sequencing profiling of BMP4-treated primary glioma cultures reveals therapeutic markers
BACKGROUND: Glioblastoma (GBM) is the most aggressive primary brain tumor. Its cellular composition is very heterogeneous, with cells exhibiting stem-cell characteristics (GSCs) that co-determine therapy resistance and tumor recurrence. Bone Morphogenetic Protein (BMP)-4 promotes astroglial and supp...
Autores principales: | Verploegh, Iris S C, Conidi, Andrea, Brouwer, Rutger W W, Balcioglu, Hayri E, Karras, Panagiotis, Makhzami, Samira, Korporaal, Anne, Marine, Jean-Christophe, Lamfers, Martine, Van IJcken, Wilfred F J, Leenstra, Sieger, Huylebroeck, Danny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713526/ https://www.ncbi.nlm.nih.gov/pubmed/35639831 http://dx.doi.org/10.1093/neuonc/noac143 |
Ejemplares similares
-
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial
por: Bos, Eelke M., et al.
Publicado: (2023) -
Generation, characterization, and drug sensitivities of 12 patient-derived IDH1-mutant glioma cell cultures
por: Verheul, Cassandra, et al.
Publicado: (2021) -
Zeb2 DNA-Binding Sites in Neuroprogenitor Cells Reveal Autoregulation and Affirm Neurodevelopmental Defects, Including in Mowat-Wilson Syndrome
por: Birkhoff, Judith C., et al.
Publicado: (2023) -
Identification of candidate enhancers controlling the transcriptome during the formation of interphalangeal joints
por: Nowosad, Karol, et al.
Publicado: (2022) -
Advancements, Challenges, and Future Directions in Tackling Glioblastoma Resistance to Small Kinase Inhibitors
por: Fabro, Federica, et al.
Publicado: (2022)